Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease

Autor: Sule Apikoglu-Rabus, Gozde Yesilyaprak, Fikret Izzettin
Přispěvatelé: Apikoglu-Rabus, Sule, Yesilyaprak, Gozde, Izzettin, Fikret Vehbi, İZZETTİN, FIKRET VEHBI
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
Turkey
Disease
Pharmacists
THERAPY
Global Burden of Disease
Pulmonary Disease
Chronic Obstructive

0302 clinical medicine
IMPROVE INHALATION TECHNIQUE
PROGRAM
030212 general & internal medicine
COPD
LED INTERVENTION
Middle Aged
Cohort
Female
INHALER TECHNIQUE
Pulmonary and Respiratory Medicine
Adult
COMMUNITY PHARMACISTS
medicine.medical_specialty
Medication Therapy Management
Pharmacist
Pharmacy
Drug-related problems
Community Pharmacy Services
Medication Adherence
03 medical and health sciences
Pharmaceutical care
ADHERENCE
Patient Education as Topic
medicine
Humans
Intensive care medicine
Asthma
business.industry
Nebulizers and Vaporizers
SMOKING-CESSATION
CARE
medicine.disease
respiratory tract diseases
Clinical pharmacy
030228 respiratory system
Pharmaceutical Services
business
Community pharmacy
Delivery of Health Care
Popis: Background: Asthma and chronic obstructive pulmonary disease are preventable and treatable chronic airway diseases with high incidence and prevalence. Pharmacists and clinical pharmacy based pharmaceutical care services have positive impact on therapy outcomes. Objective: The aim of this study is to describe drug related problems in a cohort of patients with asthma and chronic obstructive pulmonary disease and to assess interventions provided by the pharmacist to address these problems in a community pharmacy. Method: Study population consisted of patients with asthma and chronic obstructive pulmonary disease older than 18 years who visited the study pharmacy during the pre-determined six-month period. The patients whose disease control states were not fully controlled were included in our study for further steps. On the first interview, present and potential drug related problems were addressed, interventions were provided. Follow-up interviews were held one month and two months later than the first interview. Results: For the 44 patients with asthma, 59 drug-related problems and 134 causes for these problems were identified. Eighty-four interventions were made to resolve the problems; and 54.2% of the problems were resolved. For the 37 patients with chronic obstructive pulmonary disease, 60 drug-related problems and 128 causes for these problems were identified. Ninety-five interventions were made to resolve the problems; and 63.3% of the problems were resolved. Conclusion: Pharmacists taking part in therapy and management of asthma and chronic obstructive pulmonary disease can help patients be more educated about their disease and medications; and improve disease control and therapy outcomes. (C) 2016 Elsevier Ltd. All rights reserved.
Databáze: OpenAIRE